CPMV enhancer elements
Number of patents in Portfolio can not be more than 2000
United States of America Patent
Stats
-
Sep 13, 2022
Grant Date -
Feb 2, 2017
app pub date -
Jan 8, 2015
filing date -
Jan 10, 2014
priority date (Note) -
In Force
status (Latency Note)
Importance
Abstract
An expression enhancer comprising a CPMV 5′UTR nucleotide sequence consisting of X nucleotides (CMPVX), where X=160, 155, 150, or 114 of SEQ ID NO:1, or consisting of a nucleotide sequence comprising from about 80% to 100% sequence similarity with CMPVX, where X=160, 155, 150, or 114 of SEQ ID NO:1 SEQ ID NO:1 is provided. The expression enhancer may further comprise a stuffer sequence fused to the 3′ end of the 5′UTR nucleotide sequence (CMPVX+, where X=160, 155, 150, or 114 of SEQ ID NO:1). The stuffer sequence may comprise one or more plant kozak sequences. Plants comprising the expression enhancer and methods using the expression enhancer are also described.
First Claim
Other Claims data not available
Family
International Classification(s)
- 2015 Application Filing Year
- C12N Class
- 6649 Applications Filed
- 4472 Patents Issued To-Date
- 67.26 % Issued To-Date
Cited Art Landscape
Patent Citation Ranking
- 0 Citation Count
- C12N Class
- 0 % this patent is cited more than
- 3 Age
Maintenance Fees
| Fee | Large entity fee | small entity fee | micro entity fee | due date |
|---|---|---|---|---|
| 3.5 Year Payment | $1600.00 | $800.00 | $400.00 | Mar 13, 2026 |
| 7.5 Year Payment | $3600.00 | $1800.00 | $900.00 | Mar 13, 2030 |
| 11.5 Year Payment | $7400.00 | $3700.00 | $1850.00 | Mar 13, 2034 |
